PortfoliosLab logo

Acorda Therapeutics, Inc. (ACOR)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00484M6012
CUSIP00484M601
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.49
Year Range$0.30 - $4.79
EMA (50)$0.78
EMA (200)$2.14
Average Volume$2.10M
Market Capitalization$12.71M

ACORShare Price Chart


Chart placeholderClick Calculate to get results

ACORPerformance

The chart shows the growth of $10,000 invested in Acorda Therapeutics, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $32 for a total return of roughly -99.68%. All prices are adjusted for splits and dividends.


ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

ACORReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M16.67%-6.21%
YTD-79.50%-18.17%
6M-79.41%-17.47%
1Y-90.56%-8.89%
5Y-66.45%10.04%
10Y-43.23%11.39%

ACORMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ACORSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acorda Therapeutics, Inc. Sharpe ratio is -0.87. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

ACORDividend History


Acorda Therapeutics, Inc. doesn't pay dividends

ACORDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

ACORWorst Drawdowns

The table below shows the maximum drawdowns of the Acorda Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acorda Therapeutics, Inc. is 99.89%, recorded on Jun 3, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.89%Jan 27, 20151853Jun 3, 2022
-52.87%May 4, 2010359Oct 3, 2011384Apr 16, 2013743
-31.06%Apr 22, 2013181Jan 7, 2014246Dec 29, 2014427
-6.67%Jan 14, 20152Jan 15, 20156Jan 26, 20158
-5.68%Mar 12, 201014Mar 31, 20103Apr 6, 201017
-5.51%Feb 19, 20106Feb 26, 20101Mar 1, 20107
-4.29%Apr 7, 20104Apr 12, 20102Apr 14, 20106
-4.21%Jan 13, 20103Jan 15, 20104Jan 22, 20107
-4%Feb 4, 20105Feb 10, 20102Feb 12, 20107
-3.52%Mar 4, 20101Mar 4, 20103Mar 9, 20104

ACORVolatility Chart

Current Acorda Therapeutics, Inc. volatility is 285.44%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Acorda Therapeutics, Inc.


Loading data...